Coronary
Clinical Indications and Science Learning Series
ACS and Primary PCI
Advertisement
Episodes
Coronary Keynote Lecture: My Personal Guide to Prevention and Management of Primary PCI Complications
10 min.
Drug-Coated Balloon for Acute Coronary Syndromes: A Multicenter Randomized Non-inferiority Trial (DCB-ACS Trial)
15 min.
Imaging and Physiology in STEMI: Which Technology and When
15 min.
Managing STEMI No Reflow
14 min.
Giant Thrombus: Management and Options
13 min.
Pharmacology for STEMI PCI: Which Therapies Before, Options During the Case, and Management Post
13 min.
STEMI Pharmacotherapy: Oral and IV Antiplatelet Therapies, Intracoronary Lytic, Anticoagulants, and Early PCSK9 Inhibitors
16 min.
Thrombus Aspiration for STEMI Patients
13 min.
Unloading of the Left Ventricle
5 min.
Addressing Microvascular Obstruction with SSO2
5 min.
Staged Non-Culprit Lesion PCI Is Safer and Better for the Patient!
10 min.
Complete Revascularization in Patients With STEMI and MVD: CV Outcomes, Quality of Life, and Future Directions
7 min.
Immediate Non-Culprit Lesion PCI Is the Way to Go!
6 min.
STEMI State-of-the-Art: An Angiography-Guided Strategy!
3 min.
STEMI State-of-the-Art: A Physiology-Guided Strategy!
5 min.
STEMI State-of-the-Art: An Imaging-Guided Strategy!
8 min.
Reperfusion of the Infarct Related Artery With Timely Primary PCI
5 min.
Antithrombotic Therapy in ACS/PCI: Case Resolution and Long-term Therapy
8 min.
The Guidelines Need Updating: 3-6 Months of DAPT Is Sufficient
7 min.
Longer Term DAPT Is What The Guidelines and Data Support
7 min.
Antithrombotic Therapy in ACS/PCI: Case Continuation and In Hospital Management
4 min.
I Don’t Need Cangrelor With Available Potent Oral P2Y12 or 2b3a Inhibitors
10 min.
Cangrelor Reduces Procedural Complications and Should Be the Default Strategy
9 min.
Unfractionated Heparin Still Works for Primary PCI!
11 min.
Bivalirudin Is the Most Evidence Based Antithrombin Agent for Primary PCI
8 min.
Case Presentation: Antithrombotic Therapy in ACS/PCI
3 min.
Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial
24 min.
Pressure-Controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction: The Randomized PICSO-AMI-I Trial
22 min.
How I Use Intravascular Imaging to Guide PCI in Acute Coronary Syndromes
19 min.
Con: Favorable Data Is Lacking on MCS in AMI Cardiogenic Shock (Randomized Data Are Needed)
17 min.
Pro: Most Patients With AMI Cardiogenic Shock Should Get MCS (Randomization Is Unethical)
6 min.
Con: Percutaneous LVADs are not the First Line MCS device of choice for Acute MI & Cardiogenic Shock
15 min.
Pro: Percutaneous LVADs are the First Line MCS device of choice for Acute MI & Cardiogenic Shock
6 min.
Coronary Keynote Lecture: Novel Approaches to STEMI Care
10 min.
Coronary Keynote Lecture: New Concepts in Primary PCI: What Should I Be Doing Differently
11 min.
Case Presentation: Young MI with Multivessel Disease
10 min.
Refractory Cardiogenic Shock With Severe LV Dysfunction and a Mechanical Complication of Inferior Wall MI
13 min.
Unloading in AMI: Changing the Paradigm from DTB to DTU
9 min.
How Important Is Complete Revascularization?
7 min.
For Most Patients, Only Spontaneous MI Is Relevant
6 min.
Management of High Thrombus Burden in STEMI
8 min.
STEMI and MVD Update on the Evidence: Rationale for COMPLETE 2
8 min.
STEMI with Multivessel Disease: Managing the Non-Culprit Vesel
3 min.
ACS with a Large Thrombus Burden: Thrombectomy Revisited ? Guidelines Recommendations
3 min.
Thrombectomy Case Presentation
5 min.
Case Presentation: Managing the Non-Culprit Vessel in STEMI with Multivessel Disease:
4 min.
TCT 688: An Unfortuante Trifecta: A case of acute myocardial infarction with cardiogenic shock, pericardial tamponade, and worsening hypoxia with right to left shunt after percutaneous LVAD placement.
6 min.
TCT 640: POST MYOCARDIAL INFARCTION VENTRICULAR SEPTAL RUPTURE WITH HEART FAILURE AND CARDIOGENIC SHOCK : CHALLENGES AND DEVICE CLOSURE
6 min.
TCT 659: Acute Mitral Regurgitation With Unilateral Left-Sided Pulmonary Edema: A Complication of STEMI Treated Successfully With A Mitra-Clip Procedure
6 min.
Periprocedural MI Matters to All Patients!
4 min.
Should We Be Stenting All Patients Presenting With STEMI? Pros and Cons
8 min.
New and Emerging Pharmacology for ACS: Lipid Modulation and Anti-Inflammatory Agents
8 min.
New and Emerging Pharmacology for ACS: Factor XI Inhibition
6 min.
State-of-the Art: Top 10 Lessons We Have Learned In ACS Management
12 min.
Short DAPT or De-Escalation After ACS
7 min.
P2Y12 Inhibitors in ACS: Which Agent in Which Patient and When?
7 min.
Hemodynamic Support for High-Risk PCI in ACS
8 min.
PCI in STEMI - Never Treat the Non-Culprit in the Same Setting
3 min.
Management of No-Reflow in ACS
2 min.
PCI in STEMI - Complete Revascularization As Long As You Can Manage the Contrast/Hemodynamics
4 min.